Pleurodesis Using Mistletoe Extract Delivered via a Spray Catheter during Semirigid Pleuroscopy for Managing Symptomatic Malignant Pleural Effusion
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q1
- 저널
- RESPIRATION95(3) · pp.177 · 2018
- 피인용
- Web of Science 8Scopus 9
- FWCI (Scopus)
- 0.57
- JCR IF
- JCR 2017 2.591
- ISSN
- 0025-7931
저자
- 엄중섭제1저자교신저자Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
- 안효영Department of Thoracic and Cardiovascular Surgery, Pusan National University School of Medicine, Busan, South Korea
- 목정하Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 이기원Department of Radiology, Pusan National University School of Medicine, Busan, South Korea
- 조은정Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 김미현Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 이광하Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 김기욱Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 박혜경Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
- 이민기Department of Internal Medicine, Pusan National University School of Medicine, Busan, South Korea
초록
Background: Talc poudrage during thoracoscopy is considered the standard procedure for patients with symptomatic malignant pleural effusion (MPE). Until now, no alternative technique other than talc poudrage for pleurodesis during medical thoracoscopy has been proposed. Liquid sclerosants, such as mistletoe extract, have been sprayed evenly into the pleural cavity during semirigid pleuroscopy for chemical pleurodesis. Objective: We conducted a retrospective study using the database of semirigid pleuroscopy to identify the usefulness of pleurodesis using a mistletoe extract delivered via a spray catheter during semirigid pleuroscopy for symptomatic MPE. Methods: All consecutive patients with symptomatic MPE who underwent semirigid pleuroscopy from October 2015 to September 2016 were registered. The responses were evaluated using chest X-ray or computed tomography 4 weeks after pleurodesis. Results: The study included 43 patients who underwent pleurodesis with mistletoe extract via a spray catheter during semirigid pleuroscopy. Complete and partial responses were seen in 21 (49%) and 19 (44%) patients, respectively. The median duration of chest tube placement after pleurodesis was 7 days (range 6-8 days) in the 40 patients with complete or partial responses. No cases of severe hemorrhage, empyema formation, respiratory failure, or procedure-related mortality were observed in the subjects at 4 weeks after semirigid pleuroscopy. Conclusion: Pleurodesis with mistletoe extract delivered via a spray catheter during semirigid pleuroscopy is a safe and effective procedure for managing symptomatic MPE. (C) 2017 S. Karger AG, Basel
키워드
Malignant pleural effusionMistletoePleurodesisPleuroscopyTALC POUDRAGEMANAGEMENTTHORACOSCOPYSLURRY
식별자
- Scopus EID
- 2-s2.0-85033478062
- WoS UID
- 000427733000006



로그인
연구물 목록으로